5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake F...
FDA Recall #D-0265-2022 — Class II — November 30, 2021
Product Description
5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDC 0409-7100-68/0409-7100-66
Reason for Recall
Lack of sterility assurance: bag has the potential to leak.
Recalling Firm
Pfizer Inc. — New York, NY
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
765 bags
Distribution
USA Nationwide
Code Information
Lot: 4923608 Exp. 1MAY2022
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated